CompaniesA2IDEA

A2IDEA

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (13)
View all

Total Trials

13

As Lead Sponsor

10

As Collaborator

3

Total Enrollment

35,916

By Phase

NA: 3PHASE3: 4PHASE1: 1PHASE2: 5

By Status

COMPLETED: 11NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT00211549
NCT00265304
Hover over trial bars to see details

Recent Trials

NCT06131788Collaborator
Evaluation of an Educational Intervention on Abscesses in People Who Self-inject Drugs
NANot yet recruiting
440 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2026
NCT06593080Collaborator
The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis
NARecruiting
30,240 participants
Started: Jun 1, 2024 · Completed: Mar 31, 2027
NCT02142764Collaborator
Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients
NACompleted
30 participants
Started: Nov 30, 2014 · Completed: Feb 29, 2016
NCT00722852Lead Sponsor
Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee
PHASE3Completed
555 participants
Started: Jun 30, 2008 · Completed: Apr 30, 2009
NCT00716547Lead Sponsor
Safety and Efficacy of Two Dosages of Diractin® in Osteoarthritis (OA)
PHASE3Completed
1,399 participants
Started: May 31, 2008 · Completed: May 31, 2009
View all 13 trials →